Analysis of a New High Throughput Screening Detection Technology for Rapid hERG Safety Testing Using a Fluorescence Polarization Assay
21 Oct 2012

The vast majority of drugs associated with acquired QT prolongation are known to interact with hERG. In this application note from BioTek, the use if the Synergy™ Neo HTS detection platform for hERG screening via a fluorescence polarization based assay is described. Using assay controls and a panel of multiple hERG inhibitors, analysis of pharmacology endpoints for instrument validation include Z’, assay window, precision and plate read times. Additionally, FP-based IC50 data is generated and compared to data from traditional electrophysiological and radiometric methods.

Popular tags in SelectScience

Buying guides

Write a Review

Join the Global SelectScience Community Today! It’s FREE!

Helping you make informed decisions about the latest lab products and technologies:

  • Be the first to learn about new technologies
  • 10,000+ trusted product reviews from your peers
  • Compare 500,000 products and manufacturers
  • Get exclusive buying tips from experts
  • Find solutions fast: 10,000+ Application Notes, Webinars and Videos

Connect with 250,000 scientists... All in one place!

Become a member today!